[Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis].
Pérez Prim
F J
FJ
Vila
I
I
D000368:Aged; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D000935:Antifungal Agents / Q000627:therapeutic use; D002176:Candida albicans / Q000302:isolation & purification*; D002180:Candidiasis, Oral / Q000139:chemically induced* / Q000628:therapy; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D009761:Nystatin / Q000627:therapeutic use; D009853:Omeprazole / Q000009:adverse effects*; D017211:Treatment Failure
D000897:Anti-Ulcer Agents; D000935:Antifungal Agents; D009761:Nystatin; D015725:Fluconazole; D009853:Omeprazole